Science Corporation's vision chip implanted in first Stargardt patient
Max Hodak, former Neuralink president, said the PRIMA implant is part of a path toward a brain-computer interface.
By Standard Topic. AI-generated from the reporting listed under Coverage. Published . Updated .
This story is no longer being updated. It reflects reporting up to .
What happened
Science Corporation has implanted its vision-restoring chip, called PRIMA, in its first patient with Stargardt disease. Max Hodak, the former president and co-founder of Neuralink, described the work on stage at TechCrunch Disrupt. Coverage also says the Prima system lets people with advanced macular degeneration read and do crosswords.
Why it matters
The work is part of Science Corporation's path toward a novel brain-computer interface. The system could restore sight for patients with advanced macular degeneration.
Timeline
- Oct 13, 7:13 PM ET: Max Hodak detailed the company's PRIMA work and its path toward a brain-computer interface at TechCrunch Disrupt.
- Oct 16, 5:00 AM ET: Coverage reported that the Prima system lets people with advanced macular degeneration read and do crosswords.
Coverage
- This implant can restore sight for patients with macular degeneration (technologyreview.com)
- Science Corporation implants its vision-restoring chip in its first Stargardt disease patient (techcrunch.com)
More from Science
- Citrini Research designs 211 proteins with Claude AI
- Researchers find two methods to break down PFAS chemicals
- International team measures early Universe helium with record precision
- British Academy launches report on universities' research funding future
- Researchers find previously unknown chicken immune cell population
- Daily blueberries linked to fewer depression symptoms in small study